Bosh sahifaNBY • NYSEAMERICAN
add
NovaBay Pharmaceuticals Inc
1,04 $
Seans yopilganidan keyin:(0,00%)0,00
1,04 $
Yopilgan:17-okt, 19:55:33 (GMT-4) · USD · NYSEAMERICAN · Ogohlantirish
Yopilish kursi
1,14 $
Kunlik diapazon
1,01 $ - 1,14 $
Yillik diapazon
0,46 $ - 4,44 $
Bozor kapitalizatsiyasi
6,25 mln USD
Oʻrtacha hajm
1,39 mln
Narx/foyda
6,49
Dividend daromadliligi
-
Yangiliklarda
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (USD) | iyn, 2025info | Y/Y qiyosi |
|---|---|---|
Daromad | — | — |
Joriy xarajat | 1,89 mln | 16,94% |
Sof foyda | -1,92 mln | -21,26% |
Sof foyda marjasi | — | — |
Har bir ulushga tushum | — | — |
EBITDA | -1,89 mln | -17,32% |
Amaldagi soliq stavkasi | — | — |
Balans
Jami aktivlari
Jami passivlari
| (USD) | iyn, 2025info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 5,34 mln | 611,58% |
Jami aktivlari | 6,91 mln | 76,08% |
Jami passivlari | 2,67 mln | -41,30% |
Umumiy kapital | 4,24 mln | — |
Tarqatilgan aksiyalar | 5,82 mln | — |
Narxi/balansdagi bahosi | 1,56 | — |
Aktivlardan daromad | -56,34% | — |
Kapitaldan daromad | -75,16% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
| (USD) | iyn, 2025info | Y/Y qiyosi |
|---|---|---|
Sof foyda | -1,92 mln | -21,26% |
Operatsiyalardan naqd pul | -2,95 mln | -408,45% |
Sarmoyadan naqd pul | — | — |
Moliyadan naqd pul | -174,00 ming | 64,63% |
Naqd pulning sof oʻzgarishi | -3,12 mln | -191,32% |
Boʻsh pul | -2,31 mln | -366,84% |
Haqida
NovaBay Pharmaceuticals, Inc. is an Emeryville, California based clinical-stage biopharmaceutical company, focused on products for eye care. Major products include Avenova, cleared by FDA for lid and lash cleansing as part of a regimen for Blepharitis. and NeutroPhase, used in treatment of Necrotizing Fasciitis Wikipedia
Tashkil etilgan
2000
Sayt
Xodimlar soni
14
